(Q39877036)

English

Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

author name string

M A Zanta-Boussif

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

S Charrier

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

A Brice-Ouzet

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

S Martin

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

P Opolon

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

A J Thrasher

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

T J Hope

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

A Galy

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

5 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

605-619

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

https://scigraph.springernature.com/pub.10.1038/gt.2009.3

0 references

Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

CRM1-dependent function of a cis-acting RNA export element

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE).

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Hepadna virus integration generates virus-cell cotranscripts carrying 3' truncated X genes in human and woodchuck liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Physiological promoters reduce the genotoxic risk of integrating gene vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

One step screening of retroviral producer clones by real time quantitative PCR.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

21 January 2018

Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Corrigendum to "Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models".

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/GT.2009.3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39877036&oldid=2091932206"